812664-93-0 Usage
Description
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chloromethyl]sulfinyl]-1H-benzimidazole is a complex organic compound with a unique molecular structure that features a benzimidazole core, difluoromethoxy and chloromethyl substituents, and a sulfinyl linkage to a 3,4-dimethoxy-2-pyridinyl group. 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chloromethyl]sulfinyl]-1H-benzimidazole exhibits specific chemical properties and potential applications in various fields due to its distinct structural features.
Uses
Used in Pharmaceutical Industry:
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chloromethyl]sulfinyl]-1H-benzimidazole is used as an impurity in the synthesis of Pantoprazole (P183000), which is an antiulcerative and gastric pump inhibitor. The presence of this compound as an impurity is significant for quality control and ensuring the safety and efficacy of Pantoprazole as a pharmaceutical product.
While the provided materials do not specify other industries or applications for this compound, its unique structure suggests that it may have potential uses in various fields such as chemical research, material science, or as an intermediate in the synthesis of other complex organic molecules. Further investigation and research would be required to explore and confirm these potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 812664-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,2,6,6 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 812664-93:
(8*8)+(7*1)+(6*2)+(5*6)+(4*6)+(3*4)+(2*9)+(1*3)=170
170 % 10 = 0
So 812664-93-0 is a valid CAS Registry Number.
812664-93-0Relevant articles and documents
PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE
-
Page 26-27, (2008/06/13)
The present invention provides a process comprising admixing a thioether with about 1.05 to about 1.6 molar equivalents of an active chlorine-containing oxidant, preferably sodium hypochlorite, and about 2.5 to about 5.0 molar equivalents of an alkali metal base; and recovering a sulfoxide that is preferably pantoprazole, lansoprazole, omeprazole, or rabeprazole. The process may further comprise contacting the sulfoxide with a source of sodium ions, preferably sodium hydroxide, to produce the sodium salt of the sulfoxide. The invention also relates to novel chlorinated derivatives of pantoprazole including 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chloromethyl]sulfinyl]-1H- benzimidazole and 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chlorohydroxymethyl] sulfinyl]-1H-benzimidazole and processes for making them. The invention also relates to processes of quantifying and identifying a compound other than pantoprazole in a mixture of pantoprazole and at least one other compound.
